As researchers seek better drugs for breast cancer, they have a revealing new picture that could guide their way. It shows where the breast cancer drug Herceptin binds to and inhibits the protein HER2 on cancer-cell surfaces.
Note: To comment, Science News subscribing members must now establish a separate login relationship with Disqus. Click the Disqus icon below, enter your e-mail and click “forgot password” to reset your password. You may also log into Disqus using Facebook, Twitter or Google.